IL139596A0 - Novel formulation containing paroxetine - Google Patents

Novel formulation containing paroxetine

Info

Publication number
IL139596A0
IL139596A0 IL13959699A IL13959699A IL139596A0 IL 139596 A0 IL139596 A0 IL 139596A0 IL 13959699 A IL13959699 A IL 13959699A IL 13959699 A IL13959699 A IL 13959699A IL 139596 A0 IL139596 A0 IL 139596A0
Authority
IL
Israel
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
novel
Prior art date
Application number
IL13959699A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL139596A0 publication Critical patent/IL139596A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13959699A 1998-05-13 1999-05-13 Novel formulation containing paroxetine IL139596A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
IL139596A0 true IL139596A0 (en) 2002-02-10

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13959699A IL139596A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077685A2 (id)
JP (1) JP2002514593A (id)
KR (1) KR20010043545A (id)
CN (1) CN1309557A (id)
AP (1) AP2000001985A0 (id)
AU (1) AU3941099A (id)
BG (1) BG105011A (id)
BR (1) BR9910402A (id)
CA (1) CA2331849A1 (id)
EA (1) EA200001173A1 (id)
GB (1) GB9810180D0 (id)
HU (1) HUP0101931A3 (id)
ID (1) ID27018A (id)
IL (1) IL139596A0 (id)
NO (1) NO20005681L (id)
PL (1) PL344872A1 (id)
SK (1) SK16972000A3 (id)
TR (1) TR200003351T2 (id)
WO (1) WO1999058116A2 (id)
ZA (1) ZA200006465B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3810100A (en) 1999-03-12 2000-10-04 Basf Aktiengesellschaft Stable pharmaceutical application form for paroxetin anhydrate
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
ZA200006465B (en) 2001-11-09
JP2002514593A (ja) 2002-05-21
AU3941099A (en) 1999-11-29
HUP0101931A2 (hu) 2002-04-29
GB9810180D0 (en) 1998-07-08
NO20005681D0 (no) 2000-11-10
BG105011A (en) 2001-07-31
EP1077685A2 (en) 2001-02-28
NO20005681L (no) 2000-12-01
TR200003351T2 (tr) 2001-03-21
EA200001173A1 (ru) 2001-04-23
CN1309557A (zh) 2001-08-22
BR9910402A (pt) 2001-01-09
WO1999058116A2 (en) 1999-11-18
ID27018A (id) 2001-02-22
CA2331849A1 (en) 1999-11-18
SK16972000A3 (sk) 2001-06-11
AP2000001985A0 (en) 2000-12-31
HUP0101931A3 (en) 2002-10-28
KR20010043545A (ko) 2001-05-25
PL344872A1 (en) 2001-11-19
WO1999058116A3 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
EP1016400A4 (en) COMPOSITION FOR EXTERNAL USE
GB9809058D0 (en) Composition
PT1466615E (pt) Composição farmacêutica
PL343769A1 (en) Pharmaceutical composition
GB9818591D0 (en) Pharmaceutical composition
GB9812119D0 (en) Composition
PL334568A1 (en) Paroxetin containing compositions
GB9806788D0 (en) Composition
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
IL136106A0 (en) Formulations comprising dissolved paroxetine
GB9806793D0 (en) Composition
GB2331703B (en) Disinfectant compositions
IL139596A0 (en) Novel formulation containing paroxetine
PL344137A1 (en) Novel composition
PL343095A1 (en) Paroxetine compositions
IL139594A0 (en) Novel formulation containing paroxetine
GB9904523D0 (en) Platinum (11) compounds
GB9804041D0 (en) Composition
HU9800078D0 (en) Pharmaceutical composition
GB9806791D0 (en) Composition
HK1034904A (en) Novel formulation containing paroxetine
HK1034905A (en) Novel formulation containing paroxetine
GB9818905D0 (en) Novel formulation
GB9818910D0 (en) Novel formulation